Crescent Biopharma, Inc. (CBIO)
NASDAQ·Healthcare·Biotechnology
$14.23
-13.08%
Mkt Cap $627.36M
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (5 analysts)
$29.00
Range $29.00 – $29.00
Implied Upside
+103.8%
Consensus $29.00 vs current $14.23
NASDAQ·Healthcare·Biotechnology
$14.23
-13.08%
Mkt Cap $627.36M
Buy
2
Hold
1
Sell
0
Price Target (5 analysts)
$29.00
Range $29.00 – $29.00
+103.8%
Consensus $29.00 vs current $14.23